Plant Comparison
Cranberry vs Pygeum
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Cranberry and Pygeum: they share 4 indicated uses (arthritis / joint pain, inflammation (general), skin irritation, …); 1 pharmacological action in common.
Evidence face-off — shared uses
| Condition | Cranberry | Pygeum | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 5/10 | Stronger for Pygeum |
| Inflammation (general) | 2/10 | 2/10 | Comparable evidence |
| Skin irritation | 1/10 | 5/10 | Stronger for Pygeum |
| Urinary support | 5/10 | 10/10 | Stronger for Pygeum |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The A-type proanthocyanidins are considered responsible for inhibiting bacterial adhesion to the urinary tract lining.
Give the fruit its characteristic tartness and are traditionally credited with a mild urinary-acidifying effect.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Supports lower urinary tract symptoms of benign prostatic hyperplasia (BPH) - a Cochrane meta-analysis of 18 RCTs (1562 men) found a moderate improvement in urinary symptoms and flow versus placebo, but the trials were small, short and methodologically weak, so the evidence remains uncertain
inferred from anti-inflammatory action
Supports lower urinary tract symptoms of benign prostatic hyperplasia (BPH) - a Cochrane meta-analysis of 18 RCTs (1562 men) found a moderate improvement in urinary symptoms and flow versus placebo, but the trials were small, short and methodologically weak, so the evidence remains uncertain
Supports lower urinary tract symptoms of benign prostatic hyperplasia (BPH) - a Cochrane meta-analysis of 18 RCTs (1562 men) found a moderate improvement in urinary symptoms and flow versus placebo, but the trials were small, short and methodologically weak, so the evidence remains uncertain
Safety, Cautions & Contraindications
Food amounts are generally considered safe (berries in meals, drinks, sauces). (Williams et al., 2023).
Duke (2002) includes cranberry primarily at the experimental level for its astringent, diuretic, and antioxidant properties. Commission E has not approved cranberry for specific indications, though there is evidence supporting its role in preventing urinary tract infections (UTIs) by inhibiting bacterial adhesion to uroepithelial cells (proanthocyanidins). Duke notes the high vitamin C and organic acid content. Food-grade consumption is considered safe and beneficial as a urinary acidifier (Duke, 2002).
Lower urinary tract / prostate symptoms must be medically assessed first to exclude prostate cancer. The evidence is mixed and rests on small, short, methodologically weak trials, so men with moderate or severe BPH should not rely on it instead of proven treatment.
Generally well tolerated, with mild gastrointestinal effects the most common report.
External Ids
Botanical Description
Low, creeping, evergreen dwarf shrub (Ericaceae) with slender, wiry stems that root at the nodes. Leaves are tiny, alternate, leathery and ovate with in-rolled margins, dark green above and whitish beneath. Flowers are small, pink and four-petalled, sharply reflexed backward so that the protruding stamens and style resemble a crane's head and neck - the origin of the name 'craneberry', later shortened to 'cranberry'. The fruit is a small, round, tart red berry.[8]
Evergreen tree (Rosaceae), 10-30 m tall, with dark, fissured, red-brown bark (the source of the common name 'red stinkwood', from its unpleasant smell when cut). Leaves are glossy dark green, leathery, oblong with finely toothed margins. Small white, five-petalled flowers are borne in axillary racemes, followed by small reddish-brown, two-lobed fruit.
Habitat
Native to boggy, acidic wetlands - sphagnum bogs and marshes - across northern and central Europe and northern Asia, requiring waterlogged, nutrient-poor, acidic peat soils.[8]
Native to montane forests of central and southern Africa (and Madagascar), growing at moderate to high altitude (roughly 900-3400 m). The species is CITES-listed and conservation-threatened owing to over-harvesting of bark for the pharmaceutical trade.
Harvesting
Berries are hand-picked or wet-harvested (traditionally by hand-raking the bog) in autumn once fully ripe and deep red.[8]
Bark is traditionally stripped from mature trees. Unsustainable stripping - especially removing bark all the way round the trunk - kills the tree and has driven population decline, so sustainable, partial and rotational bark harvesting or cultivated sources are recommended.
Traditional Uses
Cranberry has a long northern-European and Native American tradition as a food and folk remedy for urinary complaints, valued for its tart, astringent, vitamin-C-rich fruit. Modern research on its proanthocyanidins supports a role in reducing bacterial adhesion in the urinary tract, consistent with the traditional use for cystitis and recurrent urinary tract infections.[2, 11]
Prunus africana bark has a traditional use in East and Central African ethnomedicine for urinary complaints, and its extract (marketed as Pygeum) became one of the most widely used European phytotherapy remedies for benign prostatic hyperplasia (BPH) symptoms in the 20th century. Clinical evidence for symptom benefit is moderate but drawn from small, methodologically weak trials.[11]
Preparations
The clinically studied commercial form, standardised for phytosterol content.
References
Lookalikes Review
Dosage
Not documented
Clinical trials have most often used around 100-200 mg/day of standardised lipophilic bark extract, divided into two doses. Educational reference only, not a prescription; any prostate or urinary symptom should be medically assessed first.
References & Sources
- Shareef, S.M., Khaleel, R.A. and Maryoosh, T.M (2024) 'Nephroprotective effect of cranberry (Vaccinium oxycoccos) in streptozocin-induced diabetic nephropathy in mice', Drug Metabolism and Personalized Therapy, 39(1), pp. 35-45. doi:10.1515/dmpt-2023-0092 Preclinical
https://doi.org/10.1515/dmpt-2023-0092 - Jurikova, T., Skrovankova, S., Mlcek, J., Balla, S. and Snopek, L (2018) 'Bioactive Compounds, Antioxidant Activity, and Biological Effects of European Cranberry (Vaccinium oxycoccos)', Molecules, 24(1), pp. 24. doi:10.3390/molecules24010024 Traditional / reference
https://doi.org/10.3390/molecules24010024 - Sedbare, R., Raudone, L., Zvikas, V., Viskelis, J. and others (2022) 'Development and Validation of the UPLC-DAD Methodology for the Detection of Triterpenoids and Phytosterols in Fruit Samples of Vaccinium macrocarpon Aiton and Vaccinium oxycoccos L', Molecules, 27(14), pp. 4403. doi:10.3390/molecules27144403 Preclinical
https://doi.org/10.3390/molecules27144403 - Sedbare, R., Sprainaityte, S., Baublys, G., Viskelis, J. and Janulis, V (2023) 'Phytochemical Composition of Cranberry (Vaccinium oxycoccos L.) Fruits Growing in Protected Areas of Lithuania', Plants (Basel), 12(10), pp. 1974. doi:10.3390/plants12101974 Preclinical
https://doi.org/10.3390/plants12101974 - Brown, P.N., Turi, C.E., Shipley, P.R. and Murch, S.J (2012) 'Comparisons of large (Vaccinium macrocarpon Ait.) and small (Vaccinium oxycoccos L., Vaccinium vitis-idaea L.) cranberry in British Columbia by phytochemical determination, antioxidant potential, and metabolomic profiling with chemometric analysis', Planta Medica, 78(6), pp. 630-640. doi:10.1055/s-0031-1298239 Preclinical
https://doi.org/10.1055/s-0031-1298239 - Harini, K., Janani, K., Teja, K.V., Mohan, C. and Sukumar, M (2022) 'Formulation and evaluation of oral disintegrating films using a natural ingredient against Streptococcus mutans', Journal of Conservative Dentistry, 25(2), pp. 128-134. doi:10.4103/jcd.jcd_143_21 Preclinical
https://doi.org/10.4103/jcd.jcd_143_21 - Cesoniene, L., Daubaras, R., Jasutiene, I., Vencloviene, J. and Miliauskiene, I (2011) 'Evaluation of the biochemical components and chromatic properties of the juice of Vaccinium macrocarpon Aiton and Vaccinium oxycoccos L', Plant Foods for Human Nutrition, 66(3), pp. 238-244. doi:10.1007/s11130-011-0241-5 Preclinical
https://doi.org/10.1007/s11130-011-0241-5 - Van Rossum, F., Vereecken, N.J., Bredat, E. and Michez, D (2012) 'Pollen dispersal and fruit production in Vaccinium oxycoccos and comparison with its sympatric congener V. uliginosum', Plant Biology, 15(2), pp. 344-352. doi:10.1111/j.1438-8677.2012.00646.x Preclinical
https://doi.org/10.1111/j.1438-8677.2012.00646.x - Kawash, J., Colt, K., Hartwick, N.T., Abramson, B.W. and others (2022) 'Contrasting a reference cranberry genome to a crop wild relative provides insights into adaptation, domestication, and breeding', PLoS One, 17(3), pp. e0264966. doi:10.1371/journal.pone.0264966 Preclinical
https://doi.org/10.1371/journal.pone.0264966 - Stobnicka, A. and Gniewosz, M (2017) 'Antimicrobial protection of minced pork meat with the use of Swamp Cranberry (Vaccinium oxycoccos L.) fruit and pomace extracts', Journal of Food Science and Technology, 55(1), pp. 62-71. doi:10.1007/s13197-017-2770-x Preclinical
https://doi.org/10.1007/s13197-017-2770-x - Hooton, T.M., Vecchio, M., Iroz, A., Tack, I., Dornic, Q., Seksek, I. and Lotan, Y (2018) 'Effect of increased daily water intake in premenopausal women with recurrent urinary tract infections: a randomized clinical trial', 178(11), pp. 1509--1515. doi:10.1001/jamainternmed.2018.4204 Randomized trial
https://doi.org/10.1001/jamainternmed.2018.4204 - Jepson, R.G., Williams, G. and Craig, J.C (2012) 'Cranberries for preventing urinary tract infections'. Traditional / reference
https://scholar.google.com/scholar?q=Cranberries%20for%20preventing%20urinary%20tract%20infections - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
- Thompson, R.Q., Katz, D. and Sheehan, B (2019) 'Chemical comparison of Prunus africana bark and pygeum products marketed for prostate health', Journal of Pharmaceutical and Biomedical Analysis, 163, pp. 162-169. doi:10.1016/j.jpba.2018.10.004 Preclinical
https://doi.org/10.1016/j.jpba.2018.10.004 - Dvorkin, L. and Song, K.Y (2002) 'Herbs for benign prostatic hyperplasia', The Annals of Pharmacotherapy, 36(9), pp. 1443-1452. doi:10.1345/aph.1A228 Meta-analysis / review
https://doi.org/10.1345/aph.1A228 - Keehn, A. and Lowe, F.C (2015) 'Complementary and alternative medications for benign prostatic hyperplasia', The Canadian Journal of Urology, 22(Suppl 1), pp. 18-23. Meta-analysis / review
https://scholar.google.com/scholar?q=Complementary%20and%20alternative%20medications%20for%20benign%20prostatic%20hyperplasia - Kim, T.H., Lim, H.J., Kim, M.S. and Lee, M.S (2012) 'Dietary supplements for benign prostatic hyperplasia: an overview of systematic reviews', Maturitas, 73(3), pp. 180-185. doi:10.1016/j.maturitas.2012.07.007 Meta-analysis / review
https://doi.org/10.1016/j.maturitas.2012.07.007 - Cambronero, J., Osca-Garcia, J.M., Merino-Salas, S., Miguel, J.M. and others (2022) 'Effectiveness of treatment with Pygeum africanum in patients with lower urinary tract symptoms and benign prostatic hyperplasia: a cross-sectional study in the real-world clinical practice in Spain (The PROFIT Study)', Archivos Espanoles de Urologia, 75(3), pp. 219-227. Clinical study
https://scholar.google.com/scholar?q=Effectiveness%20of%20treatment%20with%20Pygeum%20africanum%20in%20patients%20with%20lower%20urinary%20tract%20symptoms%20and%20benign%20prostatic%20hyperplasia%3A%20a%20cross-sectional%20study%20in%20the%20real-world%20clinical%20practice%20in%20Spain%20%28The%20PROFIT%20Study%29 - Quiles, M.T., Arbos, M.A., Fraga, A., de Torres, I.M. and others (2010) 'Antiproliferative and apoptotic effects of the herbal agent Pygeum africanum on cultured prostate stromal cells from patients with benign prostatic hyperplasia (BPH)', The Prostate, 70(10), pp. 1044-1053. doi:10.1002/pros.21138 Preclinical
https://doi.org/10.1002/pros.21138 - Salinas-Casado, J., Esteban-Fuertes, M., Carballido-Rodriguez, J. and Cozar-Olmo, J.M (2020) 'Review of the experience and evidence of Pygeum africanum in urological practice', Actas Urologicas Espanolas, 44(1), pp. 9-13. doi:10.1016/j.acuro.2019.08.002 Meta-analysis / review
https://doi.org/10.1016/j.acuro.2019.08.002 - Villar, A., Silva-Fuentes, F., Mula, A. and Zangara, A (2024) 'Anti-Inflammatory Potential of Prunus africana Bark Extract: An In Vitro Study of Cytokine Release by Lipopolysaccharide-Stimulated Human Peripheral Blood Mononuclear Cells', International Journal of Molecular Sciences, 25(15), pp. 8298. doi:10.3390/ijms25158298 Preclinical
https://doi.org/10.3390/ijms25158298 - Larre, S., Camparo, P., Comperat, E., Boulbes, D. and others (2012) 'Biological effect of human serum collected before and after oral intake of Pygeum africanum on various benign prostate cell cultures', Asian Journal of Andrology, 14(3), pp. 499-504. doi:10.1038/aja.2011.132 Preclinical
https://doi.org/10.1038/aja.2011.132 - Rubegeta, E., Makolo, F., Kamatou, G., Enslin, G. and others (2023) 'The African cherry: A review of the botany, traditional uses, phytochemistry, and biological activities of Prunus africana (Hook.f.) Kalkman', Journal of Ethnopharmacology, 305, pp. 116004. doi:10.1016/j.jep.2022.116004 Meta-analysis / review
https://doi.org/10.1016/j.jep.2022.116004 - Keehn, A. and Lowe, F.C (2015) 'Complementary and alternative medications for benign prostatic hyperplasia', The Canadian Journal of Urology. Randomized trial
https://scholar.google.com/scholar?q=Complementary%20and%20alternative%20medications%20for%20benign%20prostatic%20hyperplasia - Dedhia, R.C. and McVary, K.T (2008) 'Phytotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia', The Journal of Urology, 179(6), pp. 2119--2125. doi:10.1016/j.juro.2008.01.094 Meta-analysis / review
https://doi.org/10.1016/j.juro.2008.01.094 - Wilt, T. and Ishani, A. and Mac Donald, R. and Rutks, I. and Stark, G (2002) 'Pygeum africanum for benign prostatic hyperplasia', Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD001044 Meta-analysis / review
https://doi.org/10.1002/14651858.CD001044
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.